Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ ½ÃÀåÀº 2024³âºÎÅÍ 2029³â±îÁö 3¾ï 3,830¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È 7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ(HIV Rapid Test Kit) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¿¡ ´ëÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº HIV °Ë»ç¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í ÇÁ·Î±×·¥ Áõ°¡, HIV ÇöÀå °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, HIVÀÇ ³ôÀº À¯º´·ü¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ |
±âÁØ ¿¬µµ |
2025³â |
Á¾·á ¿¬µµ |
2029³â |
¿¹Ãø ±â°£ |
2025-2029³â |
¼ºÀå ¸ð¸àÅÒ |
°¡¼Ó |
YOY 2025 |
6% |
CAGR |
7% |
Áõ°¡¾× |
3¾ï 3,830¸¸ ´Þ·¯ |
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³âµ¿¾È Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î È¥Àü ¿¡ÀÌÁî °ËÁøÀ» ´Ã¸®±â À§ÇÑ ³ë·ÂÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, ¿¬±¸ÀÚµéÀÇ ÀÓ»ó ¿¬±¸ Áõ°¡¿Í Á¦Á¶¾÷üµéÀÇ È«º¸ Ȱµ¿, ±â¾÷µéÀÇ ´Ù¾çÇÑ HIV ½Å¼Ó °Ë»ç ŰƮ Á¦°øÀº ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
- °¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
- ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
- È¥¶õ ¿äÀÎ
- ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
- ½ÃÀå »ýŰè
- ½ÃÀå Æ¯Â¡
- ¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
- ½ÃÀåÀÇ Á¤ÀÇ
- ½ÃÀå ºÎ¹® ºÐ¼®
- ½ÃÀå ±Ô¸ð(2024³â)
- ½ÃÀå Àü¸Á(2024-2029³â)
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
- ¼¼°èÀÇ Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå(2019-2023³â)
- À¯Åë ä³Îº° ºÎ¹® ºÐ¼®(2019-2023³â)
- À¯Çüº° ºÎ¹® ºÐ¼®(2019-2023³â)
- ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼®(2019-2023³â)
- ¼Ò½ºº° ºÎ¹® ºÐ¼®(2019-2023³â)
- Áö¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
- ±¹°¡º° ºÎ¹® ºÐ¼®(2019-2023³â)
Á¦6Àå Á¤¼º ºÐ¼®
- AIÀÇ ¿µÇâ : ¼¼°èÀÇ Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ½Å¼Ó °Ë»ç ŰƮ ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
- Five Forces ¿ä¾à
- ¹ÙÀ̾îÀÇ ±³¼··Â
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï À§Çù
- ½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : À¯Åë ä³Îº°
- ½ÃÀå ºÎ¹®
- ºñ±³ : À¯Åë ä³Îº°
- ¿ÀÇÁ¶óÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ¿Â¶óÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ½ÃÀå ±âȸ : À¯Åë ä³Îº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : À¯Çüº°
- ½ÃÀå ºÎ¹®
- ºñ±³ : À¯Çüº°
- HIV ½Å¼Ó ¸é¿ªÃøÁ¤ °Ë»ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- HIV ½Å¼Ó ºÐÀÚÁø´Ü °Ë»ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ½ÃÀå ±âȸ : À¯Çüº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
- ½ÃÀå ºÎ¹®
- ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
- Áø´Ü¼¾ÅÍ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- º´¿ø ¹× Áø·á¼Ò : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦11Àå ½ÃÀå ¼¼ºÐÈ : ¼Ò½ºº°
- ½ÃÀå ºÎ¹®
- ºñ±³ : ¼Ò½ºº°
- Ç÷¾× : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ±¸°¾× : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ¼Òº¯ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ½ÃÀå ±âȸ : ¼Ò½ºº°
Á¦12Àå °í°´ »óȲ
Á¦13Àå Áö¿ªº° »óȲ
- Áö¿ªº° ¼¼ºÐÈ
- Áö¿ªº° ºñ±³
- ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- Çѱ¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
- ½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦14Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¾ïÁ¦¿äÀÎ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
- ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
- ½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦15Àå °æÀï ±¸µµ
- °³¿ä
- °æÀï ±¸µµ
- È¥¶õ »óȲ
- ¾÷°è ¸®½ºÅ©
Á¦16Àå °æÀï ºÐ¼®
- ±â¾÷ °³¿ä
- ±â¾÷ ¼øÀ§ Áö¼ö
- ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
- Abbott Laboratories
- AccuQuik Test Kits
- Becton Dickinson and Co.
- bioLytical Laboratories Inc.
- bioMerieux SA
- Chembio Diagnostics Inc.
- Danaher Corp.
- DrSafeHands
- F. Hoffmann La Roche Ltd.
- Fujirebio Holdings Inc.
- Healgen Scientific, LLC
- Hologic Inc.
- J. Mitra and Co. Pvt. Ltd.
- MP Biomedicals Inc.
- OraSure Technologies Inc.
Á¦17Àå ºÎ·Ï
LSH
The human immunodeficiency virus (HIV) rapid test kits market is forecasted to grow by USD 338.3 million during 2024-2029, accelerating at a CAGR of 7% during the forecast period. The report on the human immunodeficiency virus (HIV) rapid test kits market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in awareness programs for HIV testing, growing demand for point-of-care testing for HIV, and high prevalence of HIV.
Market Scope |
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 6% |
CAGR | 7% |
Incremental Value | $338.3 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's human immunodeficiency virus (HIV) rapid test kits market is segmented as below:
By Distribution Channel
By Type
- HIV rapid immunoassay test
- HIV rapid molecular diagnostic test
By End-user
- Diagnostic centers
- Hospitals and clinics
By Source
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the efforts to increase pre-marital screenings for HIV as one of the prime reasons driving the human immunodeficiency virus (HIV) rapid test kits market growth during the next few years. Also, increasing clinical studies by researchers and promotional activities by manufacturers and availability of a broad range of HIV rapid test kits by companies will lead to sizable demand in the market.
The report on the human immunodeficiency virus (HIV) rapid test kits market covers the following areas:
- Human Immunodeficiency Virus (HIV) Rapid Test Kits Market sizing
- Human Immunodeficiency Virus (HIV) Rapid Test Kits Market forecast
- Human Immunodeficiency Virus (HIV) Rapid Test Kits Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human immunodeficiency virus (HIV) rapid test kits market vendors that include Abbott Laboratories, AccuQuik Test Kits, Amkay Products Pvt. Ltd., Becton Dickinson and Co., Bhat Bio Tech India Pvt Ltd., bioLytical Laboratories Inc., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Healgen Scientific, LLC, Hologic Inc., J. Mitra and Co. Pvt. Ltd., MP Biomedicals Inc., Oragenics Inc., OraSure Technologies Inc., Pathkits, and SHINE SA. Also, the human immunodeficiency virus (HIV) rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019 - 2023
- Historic Market Size - Data Table on Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019 - 2023 ($ million)
- 5.2 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.5 Source segment analysis 2019 - 2023
- Historic Market Size - Source Segment 2019 - 2023 ($ million)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the global human immunodeficiency virus (HIV) rapid test kits market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel
- 8.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 8.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 8.3 Offline - Market size and forecast 2024-2029
- Chart on Offline - Market size and forecast 2024-2029 ($ million)
- Data Table on Offline - Market size and forecast 2024-2029 ($ million)
- Chart on Offline - Year-over-year growth 2024-2029 (%)
- Data Table on Offline - Year-over-year growth 2024-2029 (%)
- 8.4 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ million)
- Data Table on Online - Market size and forecast 2024-2029 ($ million)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 9.3 HIV rapid immunoassay test - Market size and forecast 2024-2029
- Chart on HIV rapid immunoassay test - Market size and forecast 2024-2029 ($ million)
- Data Table on HIV rapid immunoassay test - Market size and forecast 2024-2029 ($ million)
- Chart on HIV rapid immunoassay test - Year-over-year growth 2024-2029 (%)
- Data Table on HIV rapid immunoassay test - Year-over-year growth 2024-2029 (%)
- 9.4 HIV rapid molecular diagnostic test - Market size and forecast 2024-2029
- Chart on HIV rapid molecular diagnostic test - Market size and forecast 2024-2029 ($ million)
- Data Table on HIV rapid molecular diagnostic test - Market size and forecast 2024-2029 ($ million)
- Chart on HIV rapid molecular diagnostic test - Year-over-year growth 2024-2029 (%)
- Data Table on HIV rapid molecular diagnostic test - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 10.3 Diagnostic centers - Market size and forecast 2024-2029
- Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
- 10.4 Hospitals and clinics - Market size and forecast 2024-2029
- Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- 10.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
11 Market Segmentation by Source
- 11.1 Market segments
- Chart on Source - Market share 2024-2029 (%)
- Data Table on Source - Market share 2024-2029 (%)
- 11.2 Comparison by Source
- Chart on Comparison by Source
- Data Table on Comparison by Source
- 11.3 Blood - Market size and forecast 2024-2029
- Chart on Blood - Market size and forecast 2024-2029 ($ million)
- Data Table on Blood - Market size and forecast 2024-2029 ($ million)
- Chart on Blood - Year-over-year growth 2024-2029 (%)
- Data Table on Blood - Year-over-year growth 2024-2029 (%)
- 11.4 Oral fluids - Market size and forecast 2024-2029
- Chart on Oral fluids - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral fluids - Market size and forecast 2024-2029 ($ million)
- Chart on Oral fluids - Year-over-year growth 2024-2029 (%)
- Data Table on Oral fluids - Year-over-year growth 2024-2029 (%)
- 11.5 Urine - Market size and forecast 2024-2029
- Chart on Urine - Market size and forecast 2024-2029 ($ million)
- Data Table on Urine - Market size and forecast 2024-2029 ($ million)
- Chart on Urine - Year-over-year growth 2024-2029 (%)
- Data Table on Urine - Year-over-year growth 2024-2029 (%)
- 11.6 Market opportunity by Source
- Market opportunity by Source ($ million)
- Data Table on Market opportunity by Source ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.12 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.13 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.14 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 13.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.1 Market drivers
- 14.2 Market challenges
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 16.5 AccuQuik Test Kits
- AccuQuik Test Kits - Overview
- AccuQuik Test Kits - Product / Service
- AccuQuik Test Kits - Key offerings
- SWOT
- 16.6 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 16.7 bioLytical Laboratories Inc.
- bioLytical Laboratories Inc. - Overview
- bioLytical Laboratories Inc. - Product / Service
- bioLytical Laboratories Inc. - Key offerings
- SWOT
- 16.8 bioMerieux SA
- bioMerieux SA - Overview
- bioMerieux SA - Product / Service
- bioMerieux SA - Key offerings
- SWOT
- 16.9 Chembio Diagnostics Inc.
- Chembio Diagnostics Inc. - Overview
- Chembio Diagnostics Inc. - Product / Service
- Chembio Diagnostics Inc. - Key news
- Chembio Diagnostics Inc. - Key offerings
- SWOT
- 16.10 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
- 16.11 DrSafeHands
- DrSafeHands - Overview
- DrSafeHands - Product / Service
- DrSafeHands - Key offerings
- SWOT
- 16.12 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 16.13 Fujirebio Holdings Inc.
- Fujirebio Holdings Inc. - Overview
- Fujirebio Holdings Inc. - Product / Service
- Fujirebio Holdings Inc. - Key offerings
- SWOT
- 16.14 Healgen Scientific, LLC
- Healgen Scientific, LLC - Overview
- Healgen Scientific, LLC - Product / Service
- Healgen Scientific, LLC - Key offerings
- SWOT
- 16.15 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Business segments
- Hologic Inc. - Key news
- Hologic Inc. - Key offerings
- Hologic Inc. - Segment focus
- SWOT
- 16.16 J. Mitra and Co. Pvt. Ltd.
- J. Mitra and Co. Pvt. Ltd. - Overview
- J. Mitra and Co. Pvt. Ltd. - Product / Service
- J. Mitra and Co. Pvt. Ltd. - Key offerings
- SWOT
- 16.17 MP Biomedicals Inc.
- MP Biomedicals Inc. - Overview
- MP Biomedicals Inc. - Product / Service
- MP Biomedicals Inc. - Key offerings
- SWOT
- 16.18 OraSure Technologies Inc.
- OraSure Technologies Inc. - Overview
- OraSure Technologies Inc. - Business segments
- OraSure Technologies Inc. - Key news
- OraSure Technologies Inc. - Key offerings
- OraSure Technologies Inc. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.5 Data procurement
- 17.6 Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations